Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

Launched by NORTHWESTERN UNIVERSITY · Nov 2, 2022

Keywords

ClinConnect Summary

The MyCog Trial is a study designed to improve how we detect and manage cognitive issues, such as dementia and Alzheimer’s disease, especially in underserved communities. The goal is to create a practical approach that primary care doctors can use to identify cognitive impairment early and to help with the next steps in care for patients and their families. This trial will involve multiple clinics and will use a specific tool to ensure that healthcare providers can effectively spot these cognitive problems during routine visits.

To participate in the trial, individuals must be at least 16 years old and have seen a doctor at one of the 24 participating Oak Street healthcare clinics within the last three years. Importantly, participants should not have been previously diagnosed with any cognitive issues. If you join the study, you can expect to be part of a process that aims to enhance the way cognitive decline is detected and managed in your community, helping to ensure that more people receive the care they need.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • been seen by an Oak Street healthcare provider affiliated with one of the 24 enrolled practices
• • had at least one clinic visit (routine or Annual Wellness Visit) during the 3-year study period
• • not been diagnosed previously with cognitive deficits, impairments or dementias.
• Exclusion Criteria:
• • Children, adolescence, and younger adults are excluded as cognitive impairment in these populations is often due to differences other than age-related changes.